Ngā hua rapu - Arjun Law
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy mā Brent A. Williams, Arjun Law, Bertrand Routy, Neal denHollander, Vikas Gupta, Xinghua Wang, A. Chaboureau, Sowmya Viswanathan, Armand Keating
I whakaputaina 2017Artigo -
3
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploi... mā Arjun Law, María Queralt Salas, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Rajat Kumar, Hans A. Messner, Auro Viswabandya
I whakaputaina 2018Artigo -
4
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD mā Jongbok Lee, Hyeonjeong Kang, Branson Chen, Yoosu Na, Ismat Khatri, Fraser Soares, Housheng Hansen He, Arjun Law, Tianzhong Pan, Armin Gerbitz, Xiaoyu Zhu, Mark D. Minden, Li Zhang
I whakaputaina 2025Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Immunology
Medicine
Biology
Hematopoietic stem cell transplantation
Internal medicine
Transplantation
Cancer research
Gastroenterology
Graft-versus-host disease
Immune system
Myeloid leukemia
Stem cell
Anti-thymocyte globulin
Antibody
Antibody-dependent cell-mediated cytotoxicity
Astrobiology
Busulfan
CD33
CD34
CD8
Cell biology
Chemotherapy
Chills
Clinical trial
Cumulative incidence
Cyclophosphamide
Cytarabine
Fludarabine
Genetics
Haematopoiesis